StocksRunner logo
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  Highlights  
 
  Updates  
 
 
 
SELLAS Life Sciences
1.03
+3.00%
 

SLS

 

SELLAS Life Sciences Grou

$ 1.03

 
+$0.03 | +3.00%
 
 
Open
$ 1.01
 
 
MKT CAP
$ 39.68M
 
High
$ 1.07
 
 
VOL
$ 606.74K
 
Low
$ 0.96
 
 
AVG VOL
$ 1.02M
 
 
 

SLS Stock Analysis

SELLAS Life Sciences Grou (SLS) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

SLS Total Score

 
 
 

Chart

 
 

0.52

1.03

0.96

1.41

 
 
1month
3month
6month
1year
 
Total Return
SLS
vs.
S&P500
 

 
1-week Return
+1.98%
 
+1.04%
 
 
5-week Return
+101.96%
 
+4.91%
 
 
10-week Return
-12.71%
 
+7.60%
 
 
 

SLS Risk Level

This Indicator assigning SLS risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
SLS Risk Level
LOW
HIGH

Risk Volatility

 

SLS has Extreme Risk Level

Click here to check what is your level of risk

 

SLS Analysts Opinion

SLS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.20
 

SLS Momentum Analysis

 Has been gaining momentum

 

Activity

×
 

Activity

2.73
 
 

Future

×
 

Future

NA
 
 
 

SLS Analysts Opinion

SLS Analysts opinion is negative and it remained unchanged from the past 3 months

 

SLS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
56%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
60%
NA
 
On Track
On Track
On Track
 

SLS Street Opinion 

SLS Street view is bullish and have negative views on the near-term outlook

 

SLS Performance Sentiment

Sentiments overview associated with SLS events and the stock performance.
 
56%
44%
Positive
Negative
9 out of 16
events present
7 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
This Week
1.01
0.00%
 
Approvals
2 Month Ago
0.55
-3.96%
 
Insider Selling
2 Month Ago
0.58
-35.77%
 
 
 
joker
 
 
 
StocksRunner

Explore our SLS Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored FDX Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our SLS Daily Alerts

Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo

StocksRunner

Get the pulse of the market

 
StocksRunner
 
 
 
 

Stock Insights

 
 
 

Not Enough Information

 
 
 

SLS Risk Level

 
 
 

The Indicator assigning SLS risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.

 
 
SLS Risk Level
LOW
HIGH

Risk Volatility

 

SLS has Extreme Risk Level. Click here to check what is your level of risk

 
 
 
 

Stock Analysis

 
 
 
 

SLS

 

SELLAS Life Sciences Grou

$ 1.03

 
+$0.03 | +3.00%
 
  Overview  
 
  Chart  
 
  Earnings  
 
  Sentiment  
 
  News  
 
  Updates  
 

 
joker
 
 
 
Open
$ 1.01
 
 
MKT CAP
$ 39.68M
 
High
$ 1.07
 
 
VOL
$ 606.74K
 
Low
$ 0.96
 
 
AVG VOL
$ 1.02M
 
 
 

SLS Analysis

SELLAS Life Sciences Grou (SLS) still has no score becuse there is not enough information which allows us to analyze the activity of the company over a period of time
 
 

Chart

 
 

0.52

1.03

0.96

1.41

 
 
1month
3month
6month
1year
 
Total Return
SLS
vs.
S&P500
 

 
1-week Return
+1.98%
 
+1.04%
 
 
5-week Return
+101.96%
 
+4.91%
 
 
10-week Return
-12.71%
 
+7.60%
 
 
 

SLS Analysts Opinion

SLS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information

 
 

Earnings

×
 

Earnings

2.00
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.20
 

SLS Momentum Sentiment

 Has been gaining momentum

 

Activity

×
 

Activity

2.73
 
 

Future

×
 

Future

NA
 
 
 

SLS Analysts Opinion

SLS Analysts opinion is negative and it remained unchanged from the past 3 months

 

SLS Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

 
56%
Buy
Opinion
Trend
Score
Potential
Score
 
 
NA
60%
NA
 
On Track
On Track
On Track
 

SLS Street Opinion 

SLS Street view is bullish and have negative views on the near-term outlook

 
SLS Performance Sentiment
Sentiments overview associated with SLS events and the stock performance.
 
56%
44%
Positive
Negative
9 out of 16
events present
7 out of 16
events present
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Highlights
Last Modify
Price
% Change

 
Investors Activity
This Week
1.01
0.00%
 
Approvals
2 Month Ago
0.55
-3.96%
 
Insider Selling
2 Month Ago
0.58
-35.77%
 
 
SLS Latest News Feed

SELLAS Life Sciences to Present SLS009 Phase 1 Data from Acute Myeloid Leukemia Patients at the 2024 European School of Haematology (ESH) Conference: Updated Date and Time. NEW YORK Feb. 29 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc. (NASDA

Thu Feb 29, 2024

Activity

sellas life sciences gains on securing orphan drug status for r/r ptcl treatment.

Thu Jan 11, 2024

Momentum

sellas (sls) rises on fda fast track tag to leukemia candidate. sellas life sciences group inc. sls announced that the fda has granted a fast track designation to its novel and highly selective

Wed Jan 10, 2024

Activity
Momentum

sellas life receives fda fast track designation for sls009. (rttnews) - sellas life sciences group inc. (sls) announced on tuesday that its novel and highly selective cdk9 inhibitor formerly known as gfh009 and now called sls009 has been granted

Tue Jan 9, 2024

Activity

sellas life sciences gains after leukemia therapy gets fda fast track status.

Tue Jan 9, 2024

Momentum

sellas life sciences prices share offering to raise $9 mln. stock tanks 35%. (rttnews) - shares of sellas life sciences group inc. (sls) a late-stage clinical biopharmaceutical company tumbled on thursday after the announcement of the pricing of

Thu Jan 4, 2024

Activity
Momentum

sellas life sciences announces pricing of $9m public offering.

Thu Jan 4, 2024

Activity

sellas life sciences announces launch of proposed public offering.

Thu Jan 4, 2024

Activity
Activity

sellas life sciences reports proposed public offering. (rttnews) - sellas life sciences group inc. (sls) said it plans to offer and sell shares of its common stock and warrants to purchase shares of common stock in a public offering. all of the

Thu Jan 4, 2024

Activity
Activity
Activity

 
 
 
 
 

Score Tracker

 
 
 
Based on 16 events in the last 90 days from financial news and social media. Last updated Mar 4, 2024 19:26 Wall St. time
 
 

SLS Total Score

 
 
 
 
 
 
 
StocksRunner

Discover SLS Stock analysis and effective trading strategies with StocksRunner. Gain valuable insights into stock performance, market trends, and the future potential of SLS. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our SLS Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

SLS Stock trends

SLS Stock performance

SLS Stock analysis

SLS investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner ideas

Financial Reports

 
 

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
Post ×
 
0/666
joker